Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Phase 3 Completed
261 enrolled 12 charts
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
Phase 3 Completed
1,803 enrolled 20 charts
Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy
Phase 3 Completed
3,420 enrolled 19 charts
A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
Phase 3 Completed
2,049 enrolled 16 charts
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
Phase 3 Completed
1,718 enrolled 22 charts
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.
Phase 3 Completed
1,779 enrolled 14 charts
S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.
Phase 3 Completed
6,097 enrolled 20 charts
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Phase 3 Completed
645 enrolled 13 charts
NEO-ZOTAC
Phase 3 Completed
250 enrolled
EWING2008
Phase 3 Completed
907 enrolled
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
Phase 3 Completed
1,822 enrolled 19 charts
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer
Phase 3 Completed
1,904 enrolled 15 charts
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Phase 3 Completed
109 enrolled 8 charts
RADAR Trial - Randomised Androgen Deprivation and Radiotherapy
Phase 3 Completed
1,071 enrolled
ZPACT
Phase 3 Completed
250 enrolled
TRAPEZE
Phase 3 Completed
61 enrolled
Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy
Phase 3 Completed
218 enrolled
The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis
Phase 3 Completed
28 enrolled
A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors
Phase 3 Completed
487 enrolled 13 charts
Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer
Phase 3 Completed
558 enrolled
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Phase 3 Completed
439 enrolled
Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer
Phase 3 Completed
72 enrolled
ZAPCA
Phase 3 Completed
227 enrolled
The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss
Phase 3 Completed
70 enrolled 25 charts
A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC)
Phase 3 Completed
437 enrolled 14 charts
NATAN
Phase 3 Completed
654 enrolled
Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer
Phase 3 Completed
416 enrolled 10 charts
Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer
Phase 3 Completed
522 enrolled 8 charts
CTIBL
Phase 3 Completed
18 enrolled 5 charts
Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase 3 Completed
Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
Phase 3 Completed
602 enrolled 13 charts
Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
Phase 3 Completed
120 enrolled
Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss
Phase 3 Completed
135 enrolled 4 charts
Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
Phase 3 Completed
600 enrolled
Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma
Phase 3 Completed
68 enrolled 16 charts
Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.
Phase 3 Completed
1,065 enrolled 10 charts
The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer
Phase 3 Completed
527 enrolled 11 charts
Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions
Phase 3 Completed
430 enrolled 12 charts
Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
Phase 3 Completed
83 enrolled 14 charts
Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole
Phase 3 Completed
90 enrolled
Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma
Phase 3 Completed
240 enrolled